E2F8 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.57689999946697E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.7928000000399E-06 |
Normal-vs-Stage2 |
4.194600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.533700E-02 |
Stage1-vs-Stage2 |
5.355200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.874000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.596400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.43979999994914E-06 |
Normal-vs-AfricanAmerican |
3.457800E-01 |
Normal-vs-Asian |
2.261700E-03 |
Caucasian-vs-AfricanAmerican |
8.484600E-01 |
Caucasian-vs-Asian |
8.152000E-01 |
AfricanAmerican-vs-Asian |
9.096600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.582800E-03 |
Normal-vs-Female |
1.63950999999551E-05 |
Male-vs-Female |
3.465000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.234500E-04 |
Normal-vs-Extreme_Weight |
1.65508999999675E-05 |
Normal-vs-Obese |
2.314300E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.729200E-01 |
Normal_Weight-vs-Obese |
1.430000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.728820E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.669200E-01 |
Normal-vs-Age(41-60Yrs) |
1.964880E-04 |
Normal-vs-Age(61-80Yrs) |
1.075020E-03 |
Normal-vs-Age(81-100Yrs) |
3.276000E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.496800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.517200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.309200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.473000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.341600E-01 |
Normal-vs-Grade 3 |
4.889600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.640200E-02 |
Grade 2-vs-Grade 4 |
4.341600E-01 |
Grade 3-vs-Grade 4 |
4.889600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.46140000498474E-08 |
Normal-vs-N1 |
1.276030E-01 |
N0-vs-N1 |
3.704400E-01 |
|
|